# Response-Based Local Therapy for Regionally Advanced Breast Cancer

> **NCT07376538** · PHASE2 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 157 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Response-adapted comprehensive treatment strategy

## Key facts

- **NCT ID:** NCT07376538
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2028-02
- **Final completion:** 2033-02
- **Target enrollment:** 157 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07376538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07376538, "Response-Based Local Therapy for Regionally Advanced Breast Cancer". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT07376538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*